Skip to main content
. 2015 Oct 8;4(4):226–233. doi: 10.1159/000439589

Fig. 4.

Fig. 4

IFNγ-inducible chemokine levels in patients randomized to Semet (80 or 160 µg) or placebo. Intragroup differences were tested with Wilcoxon signed-rank test. p < 0.05: statistically significant. Serum CXCL-9 and −10 levels showed a significant and stable decrease in the 2 Semet groups compared to placebo.